DRAQ7: a unique real-time cell health monitor

DRAQ7™ enables real-time toxicity and viability assays

• DRAQ7™ is non-toxic to cells over several days exposure
• DRAQ7™ does not alter dose-response profiles for anti-cancer agents
• DRAQ7™ gives a sensitive real-time readout for cell death induced by hypoxia, starvation, drug treatment .. 
• DRAQ7™ has full spectral compatibility with Hoechst 33342, FITC/GFP and the orange/red MMP probes

REFERENCE:

Akagi, J. et al. Real-time cell viability assays using a new anthracycline derivative DRAQ7.

Cytomery Part A. Early View - published online November 16, 2012 DOI: 10.1002/cyto.a.22228

Read this article here

WHERE TO BUY